Filtern
Volltext vorhanden
- ja (19)
Gehört zur Bibliographie
- ja (19)
Dokumenttyp
Sprache
- Englisch (19)
Schlagworte
- angiogenesis (3)
- biomarker (3)
- prostate cancer (3)
- tumor microenvironment (3)
- cancer (2)
- kidney cancer (2)
- machine learning (2)
- metastasis (2)
- renal cell carcinoma (2)
- 68Ga-PSMA ligand PET/CT (1)
- COVID-19 (1)
- Cancer Cell (1)
- MTB (1)
- PCa (1)
- PET/CT (1)
- PSMA (1)
- PSMA-TV (1)
- RCC (1)
- SARS-CoV-2 (1)
- SOAT1 (1)
- SUV (1)
- Sunitinib (1)
- TKI (1)
- Tyrosine kinase inhibition (1)
- UMAP (1)
- agreement (1)
- androgen deprivation therapy (1)
- angiogenesis inhibitors (1)
- aplastic anemia (1)
- bone marrow failure (1)
- bone marrow immune-microenvironment (1)
- cancer care (1)
- cholesterol metabolism (1)
- clinical trials (1)
- comparability (1)
- cytopenia (1)
- detection rate (1)
- disorder of immunity (1)
- forecasting (1)
- hematopoietic stem cells (1)
- high-risk Prostate Cancer (1)
- high-risk prostate cancer (1)
- immune infiltration (1)
- immune-checkpoint inhibitor (1)
- immunotherapy (1)
- kidneys (1)
- mRNA (1)
- mTOR (1)
- metabolic tumour volume (MTV) (1)
- miR (1)
- miR-205 (1)
- miR-221-5p (1)
- miRNA (1)
- microRNA (1)
- microRNA-221 (1)
- migration (1)
- mitochondrial DNA (1)
- molecular subtypes (1)
- mtDNA (1)
- multiple myeloma (1)
- outcomes research (1)
- outreach (1)
- pan-RCC (1)
- patient access (1)
- precision medicine (1)
- precision oncology (1)
- predictive factors (1)
- prognosis (1)
- prognostic-biomarkers (1)
- proliferation (1)
- prostate adenocarcinoma (1)
- prostate-specific membrane antigen (PSMA) (1)
- radioligand therapy (1)
- real world data (1)
- recurrent prostate cancer (1)
- regression analysis (1)
- renal cancer (1)
- risk stratification (1)
- software (1)
- surgical and invasive medical procedures (1)
- surgical oncology (1)
- t-SNE (1)
- taxane (1)
- total lesion PSMA (1)
- transcriptome (1)
- transcriptomic analysis (1)
- tumor suppressor miRNA (1)
- venous infiltration (1)
- visual clustering (1)
Institut
- Urologische Klinik und Poliklinik (19)
- Comprehensive Cancer Center Mainfranken (10)
- Pathologisches Institut (6)
- Medizinische Klinik und Poliklinik II (5)
- Theodor-Boveri-Institut für Biowissenschaften (5)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (4)
- Klinik und Poliklinik für Nuklearmedizin (4)
- Center for Computational and Theoretical Biology (3)
- Medizinische Klinik und Poliklinik I (1)
Sonstige beteiligte Institutionen
Background
Despite latest advances in prostate cancer (PCa) therapy, PCa remains the third-leading cause of cancer-related death in European men. Dysregulation of microRNAs (miRNAs), small non-coding RNA molecules with gene expression regulatory function, has been reported in all types of epithelial and haematological cancers. In particular, miR-221-5p alterations have been reported in PCa.
Methods
miRNA expression data was retrieved from a comprehensive publicly available dataset of 218 PCa patients (GSE21036) and miR-221-5p expression levels were analysed. The functional role of miR-221-5p was characterised in androgen- dependent and androgen- independent PCa cell line models (C4–2 and PC-3M-Pro4 cells) by miR-221-5p overexpression and knock-down experiments. The metastatic potential of highly aggressive PC-3M-Pro4 cells overexpressing miR-221-5p was determined by studying extravasation in a zebrafish model. Finally, the effect of miR-221-5p overexpression on the growth of PC-3M-Pro4luc2 cells in vivo was studied by orthotopic implantation in male Balb/cByJ nude mice and assessment of tumor growth.
Results
Analysis of microRNA expression dataset for human primary and metastatic PCa samples and control normal adjacent benign prostate revealed miR-221-5p to be significantly downregulated in PCa compared to normal prostate tissue and in metastasis compared to primary PCa. Our in vitro data suggest that miR-221-5p overexpression reduced PCa cell proliferation and colony formation. Furthermore, miR-221-5p overexpression dramatically reduced migration of PCa cells, which was associated with differential expression of selected EMT markers. The functional changes of miR-221-5p overexpression were reversible by the loss of miR-221-5p levels, indicating that the tumor suppressive effects were specific to miR-221-5p. Additionally, miR-221-5p overexpression significantly reduced PC-3M-Pro4 cell extravasation and metastasis formation in a zebrafish model and decreased tumor burden in an orthotopic mouse model of PCa.
Conclusions
Together these data strongly support a tumor suppressive role of miR-221-5p in the context of PCa and its potential as therapeutic target.